APO Research
Talk to an analyst

APO RESEARCH · REPORT

Equine Influenza Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Equine Influenza Vaccine Industry Growth and Trends Forecast to 2032

20 December 202573 pages

Choose your research edition.

Industry ResearchEquine Influenza Vaccine Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Equine Influenza Vaccine Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Equine Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Equine Influenza Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Equine Influenza Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Equine Influenza Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Equine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Equine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Equine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Equine Influenza Vaccine include Zoetis, Merck Animal Health and Boehringer Ingelheim Vetmedica, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Equine Influenza Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Equine Influenza Vaccine market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Equine Influenza Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Equine Influenza Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Equine Influenza Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Equine Influenza Vaccine Market by Company

Zoetis

Merck Animal Health

Boehringer Ingelheim Vetmedica

Equine Influenza Vaccine Segment by Type

Liquid

Powder

Equine Influenza Vaccine Segment by Application

Home

Pet Clinic

Others

Equine Influenza Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Equine Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Influenza Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Equine Influenza Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Equine Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Liquid Table 2. Major Company of Powder Table 3. Global Equine Influenza Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Equine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 5. Global Equine Influenza Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Equine Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Equine Influenza Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Equine Influenza Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Equine Influenza Vaccine Sales by Type (2027-2032) & (W Units) Table 10. Global Equine Influenza Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Equine Influenza Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Equine Influenza Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Equine Influenza Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Equine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 15. North America Equine Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Equine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 17. Europe Equine Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Equine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Equine Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Equine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 21. Latin America Equine Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Equine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Equine Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Equine Influenza Vaccine Industry Trends Table 25. Equine Influenza Vaccine Industry Drivers Table 26. Equine Influenza Vaccine Industry Opportunities and Challenges Table 27. Equine Influenza Vaccine Industry Restraints Table 28. Global Equine Influenza Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Equine Influenza Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Equine Influenza Vaccine Sales by Company (2021-2026) & (W Units) Table 31. Global Equine Influenza Vaccine Sales Share by Company (2021-2026) Table 32. Global Equine Influenza Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Equine Influenza Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Equine Influenza Vaccine Major Company Production Sites and Headquarters Table 35. Global Equine Influenza Vaccine Company, Product Type & Application Table 36. Global Equine Influenza Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Equine Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Equine Influenza Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Equine Influenza Vaccine Sales by Region (2021-2026) & (W Units) Table 41. Global Equine Influenza Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Equine Influenza Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Equine Influenza Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Equine Influenza Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Equine Influenza Vaccine Sales by Region (2027-2032) & (W Units) Table 46. Global Equine Influenza Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Equine Influenza Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Equine Influenza Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Equine Influenza Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Equine Influenza Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Equine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 52. Global Equine Influenza Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Equine Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Equine Influenza Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Equine Influenza Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Equine Influenza Vaccine Sales by Application (2027-2032) & (W Units) Table 57. Global Equine Influenza Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Equine Influenza Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Equine Influenza Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Equine Influenza Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Equine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 62. North America Equine Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Equine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 64. Europe Equine Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Equine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Equine Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Equine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 68. Latin America Equine Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Equine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Equine Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Zoetis Company Information Table 72. Zoetis Business Overview Table 73. Zoetis Equine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Zoetis Equine Influenza Vaccine Product Portfolio Table 75. Zoetis Recent Development Table 76. Merck Animal Health Company Information Table 77. Merck Animal Health Business Overview Table 78. Merck Animal Health Equine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Merck Animal Health Equine Influenza Vaccine Product Portfolio Table 80. Merck Animal Health Recent Development Table 81. Boehringer Ingelheim Vetmedica Company Information Table 82. Boehringer Ingelheim Vetmedica Business Overview Table 83. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Product Portfolio Table 85. Boehringer Ingelheim Vetmedica Recent Development Table 86. North America Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 87. North America Equine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 88. North America Equine Influenza Vaccine Sales Market Share by Country (2021-2026) Table 89. North America Equine Influenza Vaccine Sales Forecast by Country (2027-2032) & (W Units) Table 90. North America Equine Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 91. North America Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Equine Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Equine Influenza Vaccine Market Share by Country (2021-2026) Table 94. North America Equine Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Equine Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 96. Europe Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 97. Europe Equine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 98. Europe Equine Influenza Vaccine Sales Market Share by Country (2021-2026) Table 99. Europe Equine Influenza Vaccine Sales Forecast by Country (2027-2032) & (W Units) Table 100. Europe Equine Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Equine Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Equine Influenza Vaccine Market Share by Country (2021-2026) Table 104. Europe Equine Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Equine Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Equine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 108. Asia-Pacific Equine Influenza Vaccine Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Equine Influenza Vaccine Sales Forecast by Country (2027-2032) & (W Units) Table 110. Asia-Pacific Equine Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Equine Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Equine Influenza Vaccine Market Share by Country (2021-2026) Table 114. Asia-Pacific Equine Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Equine Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 116. Latin America Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 117. Latin America Equine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 118. Latin America Equine Influenza Vaccine Sales Market Share by Country (2021-2026) Table 119. Latin America Equine Influenza Vaccine Sales Forecast by Country (2027-2032) & (W Units) Table 120. Latin America Equine Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Equine Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Equine Influenza Vaccine Market Share by Country (2021-2026) Table 124. Latin America Equine Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Equine Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Equine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 128. Middle East and Africa Equine Influenza Vaccine Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Equine Influenza Vaccine Sales Forecast by Country (2027-2032) & (W Units) Table 130. Middle East and Africa Equine Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Equine Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Equine Influenza Vaccine Market Share by Country (2021-2026) Table 134. Middle East and Africa Equine Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Equine Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Equine Influenza Vaccine Distributors List Table 139. Equine Influenza Vaccine Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Equine Influenza Vaccine Image Figure 2. Global Equine Influenza Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Equine Influenza Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Equine Influenza Vaccine Sales (2021-2032) & (W Units) Figure 5. Liquid Image Figure 6. Global Liquid Sales YoY Growth (2021-2032) & (W Units) Figure 7. Powder Image Figure 8. Global Powder Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Equine Influenza Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Equine Influenza Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Equine Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Equine Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Equine Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Equine Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Equine Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Equine Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Equine Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Equine Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Equine Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Equine Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Equine Influenza Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Home Image Figure 24. Global Home Sales YoY Growth (2021-2032) & (W Units) Figure 25. Pet Clinic Image Figure 26. Global Pet Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Equine Influenza Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Equine Influenza Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Equine Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Equine Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Equine Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Equine Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Equine Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Equine Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Equine Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Equine Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Equine Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Equine Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Equine Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Equine Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Equine Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Equine Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Equine Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Equine Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Equine Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Equine Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Equine Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Equine Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Equine Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Equine Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Equine Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Equine Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Equine Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Equine Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Equine Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Equine Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Equine Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Equine Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Equine Influenza Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Equine Influenza Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid
  • Powder
Applications
  • Home
  • Pet Clinic
  • Others
Companies covered
  • Zoetis
  • Merck Animal Health
  • Boehringer Ingelheim Vetmedica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Equine Influenza Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Equine Influenza Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Equine Influenza Vaccine Market by Type
  6. 1.3.1 Liquid
  7. 1.3.2 Powder
  8. 1.4 Global Equine Influenza Vaccine Market Size by Type
  9. 1.4.1 Global Equine Influenza Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Equine Influenza Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Equine Influenza Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Equine Influenza Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Equine Influenza Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Equine Influenza Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Equine Influenza Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Equine Influenza Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Equine Influenza Vaccine Industry Trends
  2. 2.2 Equine Influenza Vaccine Industry Drivers
  3. 2.3 Equine Influenza Vaccine Industry Opportunities and Challenges
  4. 2.4 Equine Influenza Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Equine Influenza Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Equine Influenza Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Equine Influenza Vaccine Price (2021-2026)
  4. 3.4 Global Equine Influenza Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Equine Influenza Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Equine Influenza Vaccine Company, Product Type & Application
  7. 3.7 Global Equine Influenza Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Equine Influenza Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Equine Influenza Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Equine Influenza Vaccine Tier 1, Tier 2, and Tier 3
4 Equine Influenza Vaccine Regional Status and Outlook
  1. 4.1 Global Equine Influenza Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Equine Influenza Vaccine Historic Market Size by Region
  3. 4.2.1 Global Equine Influenza Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Equine Influenza Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Equine Influenza Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Equine Influenza Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Equine Influenza Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Equine Influenza Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Equine Influenza Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Equine Influenza Vaccine by Application
  1. 5.1 Equine Influenza Vaccine Market by Application
  2. 5.1.1 Home
  3. 5.1.2 Pet Clinic
  4. 5.1.3 Others
  5. 5.2 Global Equine Influenza Vaccine Market Size by Application
  6. 5.2.1 Global Equine Influenza Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Equine Influenza Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Equine Influenza Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Equine Influenza Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Equine Influenza Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Equine Influenza Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Equine Influenza Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Equine Influenza Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zoetis
  2. 6.1.1 Zoetis Company Information
  3. 6.1.2 Zoetis Business Overview
  4. 6.1.3 Zoetis Equine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zoetis Equine Influenza Vaccine Product Portfolio
  6. 6.1.5 Zoetis Recent Developments
  7. 6.2 Merck Animal Health
  8. 6.2.1 Merck Animal Health Company Information
  9. 6.2.2 Merck Animal Health Business Overview
  10. 6.2.3 Merck Animal Health Equine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Animal Health Equine Influenza Vaccine Product Portfolio
  12. 6.2.5 Merck Animal Health Recent Developments
  13. 6.3 Boehringer Ingelheim Vetmedica
  14. 6.3.1 Boehringer Ingelheim Vetmedica Company Information
  15. 6.3.2 Boehringer Ingelheim Vetmedica Business Overview
  16. 6.3.3 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Product Portfolio
  18. 6.3.5 Boehringer Ingelheim Vetmedica Recent Developments
7 North America by Country
  1. 7.1 North America Equine Influenza Vaccine Sales by Country
  2. 7.1.1 North America Equine Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Equine Influenza Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Equine Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Equine Influenza Vaccine Market Size by Country
  6. 7.2.1 North America Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Equine Influenza Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Equine Influenza Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Equine Influenza Vaccine Sales by Country
  2. 8.1.1 Europe Equine Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Equine Influenza Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Equine Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Equine Influenza Vaccine Market Size by Country
  6. 8.2.1 Europe Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Equine Influenza Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Equine Influenza Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Equine Influenza Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Equine Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Equine Influenza Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Equine Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Equine Influenza Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Equine Influenza Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Equine Influenza Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Equine Influenza Vaccine Sales by Country
  2. 10.1.1 South America Equine Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Equine Influenza Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Equine Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Equine Influenza Vaccine Market Size by Country
  6. 10.2.1 South America Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Equine Influenza Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Equine Influenza Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Equine Influenza Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Equine Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Equine Influenza Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Equine Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Equine Influenza Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Equine Influenza Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Equine Influenza Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Equine Influenza Vaccine Value Chain Analysis
  2. 12.1.1 Equine Influenza Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Equine Influenza Vaccine Production Mode & Process
  7. 12.2 Equine Influenza Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Equine Influenza Vaccine Distributors
  10. 12.2.3 Equine Influenza Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst